Reduction in IL-10 producing B cells (Breg) in multiple sclerosis is accompanied by a reduced naïve/memory Breg ratio during a relapse but not in remission.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Journal of Neuroimmunology

• Publication date

  2011-10-28

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.jneuroim.2011.08.019PMID 21940055
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Intrathecal levels of vitamin D and IgG in multiple sclerosis

  2012cited by this paper
• Human T cells induce their own regulation through activation of B cells.

  2011cited by this paper
• B Cells as a Therapeutic Target for IFN-β in Relapsing–Remitting Multiple Sclerosis

  2011cited by this paper
• The anti-CD20 antibody rituximab reduces the Th17 cell response.

  2011cited by this paper
• Effect of vitamin D3 supplementation on peripheral B cell differentiation and isotype switching in patients with multiple sclerosis

  2011cited by this paper
• Age-Related Trends in Pediatric B-Cell Subsets

  2011cited by this paper
• B-cell subsets up-regulate α4 integrin and accumulate in the cerebrospinal fluid in clinically isolated syndrome suggestive of multiple sclerosis onset.

  2011cited by this paper
• Decreased IL-10 production mediated by Toll-like receptor 9 in B cells in multiple sclerosis.

  2010cited by this paper
• Memory B cells from a subset of treatment‐naïve relapsing‐remitting multiple sclerosis patients elicit CD4+ T‐cell proliferation and IFN‐γ production in response to myelin basic protein and myelin oligodendrocyte glycoprotein

  2010cited by this paper
• Increased osteopontin plasma levels in multiple sclerosis patients correlate with bone-specific markers

  2010cited by this paper
• CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic Lupus Erythematosus patients.

  2010cited by this paper
• IL‐10 produced by activated human B cells regulates CD4+ T‐cell activation in vitro

  2010cited by this paper
• Safety and T Cell Modulating Effects of High Dose Vitamin D3 Supplementation in Multiple Sclerosis

  2010cited by this paper
• Effects of Natalizumab on Circulating B Cells, T Regulatory Cells and Natural Killer Cells

  2010cited by this paper
• Vitamin D Status Is Positively Correlated with Regulatory T Cell Function in Patients with Multiple Sclerosis

  2009cited by this paper
• Memory and naïve B-cell subsets in patients with multiple sclerosis.

  2009cited by this paper
• Rituximab in relapsing‐remitting multiple sclerosis: A 72‐week, open‐label, phase I trial

  2008cited by this paper
• B-cell-derived interleukin-10 in autoimmune disease: regulating the regulators

  2008cited by this paper
• Association of vitamin D metabolite levels with relapse rate and disability in multiple sclerosis

  2008cited by this paper
• Multiple sclerosis

  2008cited by this paper
• Natalizumab disproportionately increases circulating pre-B and B cells in multiple sclerosis

  2008cited by this paper
• B-cell depletion with rituximab in relapsing-remitting multiple sclerosis.

  2008cited by this paper
• 1,25‐dihydroxyvitamin D3 promotes IL‐10 production in human B cells

  2008cited by this paper
• Vitamin D levels in people with multiple sclerosis and community controls in Tasmania, Australia

  2007cited by this paper
• Modulatory Effects of 1,25-Dihydroxyvitamin D3 on Human B Cell Differentiation

  2007cited by this paper
• Distinct Effector Cytokine Profiles of Memory and Naive Human B Cell Subsets and Implication in Multiple Sclerosis

  2007influential reference
• IL-10 Signaling Is Essential for 1,25-Dihydroxyvitamin D3-Mediated Inhibition of Experimental Autoimmune Encephalomyelitis1

  2006cited by this paper
• Short-lived plasma blasts are the main B cell effector subset during the course of multiple sclerosis

  2005cited by this paper
• Short-lived plasma blasts are the main B cell effector subset during the course of multiple sclerosis.

  2005cited by this paper
• Distinct Profiles of Human B Cell Effector Cytokines: A Role in Immune Regulation?1

  2004cited by this paper
• Recapitulation of B cell differentiation in the central nervous system of patients with multiple sclerosis.

  2004cited by this paper
• B cells regulate autoimmunity by provision of IL-10

  2002influential reference
• Rag-1-dependent cells are necessary for 1,25-dihydroxyvitamin D(3) prevention of experimental autoimmune encephalomyelitis.

  2001cited by this paper
• CD27: a memory B-cell marker.

  2000cited by this paper
• Analysis of somatic mutation in five B cell subsets of human tonsil

  1994cited by this paper

• The Role of B Cells in Tumorigenesis and Immunotherapy.

  2026cites this paper
• Role of B cells and pathogenic autoantibodies in autoimmune CNS and PNS neurologic diseases.

  2026cites this paper
• Reduction of regulatory B cells is associated with high-risk clinical stratification in antiphospholipid syndrome patients.

  2026cites this paper
• The vital role of CD19+CD24hiCD38hi regulatory B cells in rheumatoid arthritis: correlations with disease activity and treatment response

  2025cites this paper
• Engineering B cells to treat and study human disease

  2025cites this paper
• Differences of the 6N and 6J Substrains of C57BL/6 Mice in the Development of Experimental Autoimmune Encephalomyelitis

  2025cites this paper
• Aging‐associated changes in immunological parameters: Implications for COVID‐19 immune response in the elderly

  2025influential citation
• Multifaceted function of B cells in tumorigenesis

  2025cites this paper
• Elucidating Immune Cell Changes in Celiac Disease: Revealing New Insights from Spectral Flow Cytometry

  2025cites this paper
• Host Genetic Architecture between Epstein–Barr Virus Activity and Multiple Sclerosis Reveals Shared Pathways

  2025cites this paper
• Assessing Peripheral Blood Biomarkers and Predictive Patterns in Multiple Sclerosis Using Cytokines and Immune Gene Expression Profiles in Ocrelizumab-Treated Patients: Tracking Tumor Necrosis Factor

  2025cites this paper
• Advances and Challenges in Sepsis Management: Modern Tools and Future Directions

  2024cites this paper
• The interplay of gut microbiota and heavy metals in Multiple Sclerosis patients.

  2024cites this paper
• Epstein-Barr virus, vitamin D and the immune response: connections with consequences for multiple sclerosis

  2024cites this paper
• The current understanding of the phenotypic and functional properties of human regulatory B cells (Bregs)

  2024cites this paper
• Autoimmunity and clinical pathology amelioration in SLE by dexamethasone primed mesenchymal stem cell derived conditioned media

  2024cites this paper
• Human regulatory memory B cells defined by expression of TIM-1 and TIGIT are dysfunctional in multiple sclerosis

  2024cites this paper
• The role of Epstein-Barr virus in autoimmune and autoinflammatory diseases

  2024cites this paper
• Immune microenvironment of human papillomavirus-positive head and neck squamous cell carcinoma

  2024cites this paper
• Sustained effects on immune cell subsets and autoreactivity in multiple sclerosis patients treated with oral cladribine

  2024cites this paper
• IL-10-providing B cells govern pro-inflammatory activity of macrophages and microglia in CNS autoimmunity

  2023cites this paper
• Shift in the B cell subsets between children with type 1 diabetes and/or celiac disease

  2023cites this paper
• Multiple faces of multiple sclerosis in the era of highly efficient treatment modalities: Lymphopenia and switching treatment options challenges daily practice.

  2023cites this paper
• Effect of thymectomy on the frequencies of peripheral regulatory B and T lymphocytes in patients with Myasthenia gravis-a pilot study

  2023cites this paper
• Therapeutic targeting of gut‐originating regulatory B cells in neuroinflammatory diseases

  2023cites this paper
• Cladribine Effects on T and B Cells and T Cell Reactivity in Multiple Sclerosis

  2023cites this paper
• Systemic immune derangements are shared across various CNS pathologies and reflect novel mechanisms of immune privilege

  2023cites this paper
• Immunomodulatory effects of ocrelizumab and candidate biomarkers for monitoring treatment response in multiple sclerosis

  2023cites this paper
• Oxidative phosphorylation regulates interleukin‐10 production in regulatory B cells via the extracellular signal‐related kinase pathway

  2022cites this paper
• Regulatory T cell therapy for multiple sclerosis: Breaching (blood-brain) barriers

  2022influential citation
• The emerging role of regulatory cell-based therapy in autoimmune disease

  2022cites this paper
• Suppressive mechanisms of regulatory B cells in mice and humans

  2022cites this paper
• Autoreactive lymphocytes in multiple sclerosis: Pathogenesis and treatment target

  2022cites this paper
• Deconvolution of B cell receptor repertoire in multiple sclerosis patients revealed a delay in tBreg maturation

  2022cites this paper
• The role of B cells in cancer development

  2022cites this paper
• Ofatumumab Modulates Inflammatory T Cell Responses and Migratory Potential in Patients With Multiple Sclerosis

  2022cites this paper
• Post-therapy B Regulatory Cells Might early Predict Relapse in Hodgkin Lymphoma

  2022cites this paper
• B cells and tumor immune escape.

  2022cites this paper
• Regulatory B Cells Are Decreased and Functionally Impaired in Myasthenia Gravis Patients

  2022cites this paper
• Evolution of Anti-B Cell Therapeutics in Autoimmune Neurological Diseases

  2022cites this paper
• Regulatory Cells in Multiple Sclerosis: From Blood to Brain

  2022influential citation
• B regulatory cells in patients with autoimmune diseases: Pathogenic significance and therapeutic potential

  2022cites this paper
• The Role of Regulatory B Cells in Health and Diseases: A Systemic Review

  2021cites this paper
• Interleukin-35 Prevents Development of Autoimmune Diabetes Possibly by Maintaining the Phenotype of Regulatory B Cells

  2021cites this paper
• The impact of hypovitaminosis D and vitamin D supplementation on disease activity and immune profile in patients with multiple sclerosis

  2021cites this paper
• Serum levels and genetic variation of IL-35 are associated with multiple sclerosis: a population-based case–control study

  2021cites this paper
• Vitamin D and the Immune System

  2021cites this paper
• In vitro Immunomodulatory Effects of Human Umbilical Cord-Derived Mesenchymal Stem Cells on Peripheral Blood Cells from Warm Autoimmune Hemolytic Anemia Patients

  2021cites this paper
• Multiple sclerosis and immune system biomarkers: Novel comparison in glatiramer acetate and interferon beta-1a-treated patient groups.

  2021cites this paper
• B cells in multiple sclerosis — from targeted depletion to immune reconstitution therapies

  2021cites this paper
• The Role of Regulatory B cells in Kidney Diseases

  2021cites this paper
• B10 cells decrease fibrosis progression following cardiac injury partially by IL‐10 production and regulating hyaluronan secretion

  2021cites this paper
• Advances of Regulatory B Cells in Autoimmune Diseases

  2021influential citation
• The survival and function of IL-10-producing regulatory B cells are negatively controlled by SLAMF5

  2021cites this paper
• Frontiers of Autoantibodies in Autoimmune Disorders: Crosstalk Between Tfh/Tfr and Regulatory B Cells

  2021cites this paper
• Gut-derived acetate promotes B10 cells with antiinflammatory effects

  2021cites this paper
• Autologous hematopoietic stem cell transplantation restores the suppressive capacity of regulatory B cells in systemic sclerosis patients.

  2021cites this paper
• The identification, development and therapeutic potential of IL-10-producing regulatory B cells in multiple sclerosis.

  2021cites this paper
• Systems and Synthetic Immunology

  2020cites this paper
• Effect of vitamin D supplementation on N‐glycan branching and cellular immunophenotypes in MS

  2020cites this paper
• Interleukin 35 Regulatory B Cells.

  2020cites this paper
• An overview of lipidomic analysis in different human matrices of multiple sclerosis.

  2020cites this paper
• The Emerging Potentials of Human Regulatory B Cells Mediated Therapies in Myasthenia Gravis

  2020cites this paper
• Anti-CD20 Monoclonal Antibodies for Relapsing and Progressive Multiple Sclerosis

  2020cites this paper
• The Potential Immunoregulatory Roles of Vitamin D in Neuromyelitis Optica Spectrum Disorder.

  2020cites this paper
• A Chronological Journey of Breg Subsets: Implications in Health and Disease

  2020cites this paper
• Regulatory B cells in neuroimmunological diseases

  2020cites this paper
• Imbalance favoring follicular helper T cells over IL10+ regulatory B cells is detrimental for the kidney allograft.

  2020cites this paper
• Decoding intrathecal immunoglobulins and B cells in the CNS: their synthesis, function, and regulation

  2020cites this paper
• B Cells Improve Overall Survival in HPV-Associated Squamous Cell Carcinomas and Are Activated by Radiation and PD-1 Blockade

  2020cites this paper
• Short-term changes in frequencies of circulating leukocytes associated with narrowband UVB phototherapy in people with clinically isolated syndrome

  2019cites this paper
• B lymphocytes: Crucial contributors to brain development and neurological diseases.

  2019cites this paper
• Sexual dimorphism in Th17/Treg axis in lymph nodes draining inflamed joints in rats with collagen-induced arthritis.

  2019cites this paper
• IgM+CD27+ B cells possessed regulatory function and represented the main source of B cell-derived IL-10 in the synovial fluid of osteoarthritis patients.

  2019cites this paper
• CD24hiCD38hi B regulatory cells from patients with end plate inflammation presented reduced functional potency

  2019cites this paper
• Vitamin D as an immune modulator in multiple sclerosis.

  2019cites this paper
• Regulatory B lymphocytes: development and modulation of the host immune response during disease.

  2019cites this paper
• Low Serum Interleukin-10 Is an Independent Predictive Factor for the Risk of Second Event in Clinically Isolated Syndromes

  2019cites this paper
• CD 80 + and CD 86 + B cells as biomarkers and possible therapeutic targets in HTLV-1 associated myelopathy / tropical spastic paraparesis and multiple sclerosis

  2019cites this paper
• Vitamin D and the Immune System

  2019cites this paper
• Understanding regulatory B cells in autoimmune diseases: the case of multiple sclerosis.

  2019cites this paper
• Emerging role of innate B1 cells in the pathophysiology of autoimmune and neuroimmune diseases: association with inflammation, oxidative and nitrosative stress and autoimmune responses.

  2019cites this paper
• Inhibitory B cell co-receptors and autoimmune diseases

  2019cites this paper
• Immunologie de la sclérose en plaques

  2019cites this paper
• Research Progress of Th17/Treg Cells and Their Transcription Factors in Autoimmune Diseases

  2019cites this paper
• Mesenchymal stromal cells attenuate multiple sclerosis via IDO-dependent increasing the suppressive proportion of CD5+ IL-10+ B cells.

  2019cites this paper
• IL-10-producing regulatory B cells and plasmocytes: Molecular mechanisms and disease relevance.

  2019cites this paper
• Aberrant populations of circulating T follicular helper cells and regulatory B cells underlying idiopathic pulmonary fibrosis

  2019cites this paper
• Activated leukocyte cell adhesion molecule regulates B lymphocyte migration across central nervous system barriers

  2019cites this paper
• Resolution of inflammation during multiple sclerosis

  2019cites this paper
• Micronutrients in autoimmune diseases: possible therapeutic benefits of zinc and vitamin D.

  2019cites this paper
• The role of B regulatory (B10) cells in inflammatory disorders and their potential as therapeutic targets.

  2019cites this paper
• B cell counterpart of Treg cells: As a new target for autoimmune disease therapy

  2019cites this paper
• Pre-proof Micronutrients in autoimmune diseases : Possible therapeutic benefits of zinc and vitamin D

  2019cites this paper
• Regulatory B and T lymphocytes in multiple sclerosis: friends or foes?

  2018cites this paper
• IL-10 Producing B Cells Ability to Induce Regulatory T Cells Is Maintained in Rheumatoid Arthritis

  2018cites this paper
• The Immunologic Paradoxes of IgG4-Related Disease

  2018cites this paper
• Regulatory B Cells

  2018cites this paper
• Restoration of regulatory B cell deficiency following alemtuzumab therapy in patients with relapsing multiple sclerosis

  2018cites this paper
• Thymosins in multiple sclerosis and its experimental models: moving from basic to clinical application

  2018cites this paper